申请人:Vertex Pharmaceuticals Incorporated
公开号:US08779156B2
公开(公告)日:2014-07-15
Compounds represented by formula I
or pharmaceutically acceptable salts thereof, wherein A, B, B′, X, Y, R1, R2, R2′, R3, R3′, R4, R4′, R5, R5′, m, n, or p are as defined herein, are useful for treating flaviviridae viral infections.
公式I所代表的化合物或其药学上可接受的盐,其中A、B、B'、X、Y、R1、R2、R2'、R3、R3'、R4、R4'、R5、R5'、m、n或p的定义如本文所述,可用于治疗黄病毒科病毒感染。